Fluorine 18 piflufolastat - pylarify
Active Awarded Last action
- Contract number
- 36C24722N0171
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 7
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $5,719,999
Award facts
- Contract value 100% obligated
- $5,719,999.20 Current and potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $150,997 | |
| Supplemental Agreement for work within scope | $505,221 | |
| Exercise an Option | $1,984,796 | |
| Supplemental Agreement for work within scope | -$7,027 | |
| Supplemental Agreement for work within scope | -$140,740 | |
| Exercise an Option | $1,443,488 | |
| Supplemental Agreement for work within scope | $451,090 | |
| Exercise an Option | $631,526 | |
| Funding Only Action | $454,699 | |
| Other Administrative Action | $0 | |
| Original award | $245,950 |
Show all 11
About this award
Veterans Integrated Service Network 7 issued a delivery order to Progenics Pharmaceuticals Inc. on May 1, 2022, with a ceiling value of $5,719,999.20 for supply of PYLARIFY (fluorine 18 piflufolastat), a radiopharmaceutical diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection in veterans.
The delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered master contract vehicle supporting federal pharmaceutical procurement. Performance occurs at the awardee's manufacturing and distribution facility in North Billerica, Massachusetts, with an ultimate completion date of April 30, 2027. Pricing is firm fixed price with no set-aside designation.
Quick answers
Who was awarded contract 36C24722N0171?
36C24722N0171 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 7 (Veterans Health Administration) on May 1, 2022.
How much is contract 36C24722N0171 worth?
The government has obligated $5,719,999 on 36C24722N0171.
Is contract 36C24722N0171 an order under another contract?
Yes. 36C24722N0171 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24722N0171 competed?
The extent of competition for 36C24722N0171 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award